{"id":995878,"date":"2026-08-17T08:03:53","date_gmt":"2026-08-17T12:03:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/"},"modified":"2026-08-17T08:03:53","modified_gmt":"2026-08-17T12:03:53","slug":"glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/","title":{"rendered":"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation"},"content":{"rendered":"

<\/p>\n

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation<\/b><\/p>\n

RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE<\/a>)–
\nGlucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company’s request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel has confirmed that Glucotrack has regained compliance with Nasdaq’s stockholders’ equity requirement. The decision represents an important milestone in the Company’s efforts to strengthen its foundation and position for future growth.<\/p>\n

\n\u201cThis is an important milestone, but more significantly, it is an acknowledgment of the substantial progress we have made in repositioning Glucotrack for the future,” said Erik Emerson, Chief Executive Officer of Glucotrack. “Over the past several months, we have taken decisive actions to strengthen the Company, improve our financial foundation, and create a clearer path for long-term growth. We remain focused on executing our strategy, advancing our business objectives, and pursuing opportunities to create long-term shareholder value. We are approaching the months ahead with confidence, urgency, and a clear sense of purpose.”<\/p>\n

\nManagement remains focused on disciplined execution as it advances its strategic priorities and works toward full compliance with all applicable Nasdaq standards.<\/p>\n

About L\u014dkahi Therapeutics\u2122<\/b><\/p>\n

\nL\u014dkahi Therapeutics is a capital-efficient biopharmaceutical platform company focused on identifying, evaluating, acquiring, and advancing overlooked therapeutic assets. Through its ai\u00b2 platform and ai\u00b2 Futures Lab execution model, L\u014dkahi integrates cross-functional expertise and disciplined decision-making to drive strategic development and long-term value creation. For more information, please visit www.lokahithera.com<\/a>. For more information about the ai\u00b2 Futures Lab program, please visit www.ai2futureslab.com<\/a>.<\/p>\n

About Glucotrack, Inc.<\/b><\/p>\n

\nGlucotrack, Inc. (NASDAQ: GCTK) operates L\u014dkahi and, through its subsidiary Glucotrack Technologies, Inc., is also focused on the design, development, and commercialization of novel technologies for people with diabetes, including a long-term implantable continuous blood glucose monitoring system. The Glucotrack CBGM is an Investigational Device and is limited by federal (or United States) law to investigational use. For more information, please visit www.glucotrack.com<\/a>.<\/p>\n

Forward-Looking Statements<\/b><\/p>\n

\nThis news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements contained in this news release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as “anticipate,” “believe,” “expect,” “plan,” and “will” are intended to identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, management. These statements relate only to events as of the date on which the statements are made, and Glucotrack undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. All of the forward-looking statements made in this press release are qualified by these cautionary statements, and there can be no assurance that the actual results anticipated by Glucotrack will be realized or, even if substantially realized, that they will have the expected consequences to or effects on us or our business or operations. Readers are cautioned that certain important factors may affect Glucotrack’s actual results and could cause such results to differ materially from any forward-looking statements that may be made in this news release. Factors that may affect Glucotrack’s results include, but are not limited to, the ability of Glucotrack to raise additional capital to finance its operations (whether through public or private equity offerings, debt financings, strategic collaborations or otherwise); risks relating to regaining and maintaining compliance with Nasdaq listing requirements; risks relating to merger integration; risks relating to the receipt (and timing) of regulatory approvals (including U.S. Food and Drug Administration approval); risks relating to enrollment of patients in, and the conduct of, clinical trials; risks relating to Glucotrack’s future distribution agreements; risks relating to its ability to hire and retain qualified personnel; and the additional risk factors described in Glucotrack’s filings with the U.S. Securities and Exchange Commission (the “SEC”), including its Annual Report on Form 10-K for the year ended December 31, 2025 as filed with the SEC on March 30, 2026.<\/p>\n

\"\"<\/p>\n

View source version on businesswire.com: <\/span>https:\/\/www.businesswire.com\/news\/home\/20260817183116\/en\/<\/a><\/span><\/p>\n

Glucotrack
\n<\/b>
GlucotrackPR@icrinc.com
\n<\/a>
L\u014dkahi Therapeutics\u2122
\n<\/b>
ir@lokahithera.com<\/a><\/p>\n

KEYWORDS:<\/b> California New Jersey United States North America<\/p>\n

INDUSTRY KEYWORDS:<\/b> Medical Devices Health Diabetes Health Technology Pharmaceutical Biotechnology<\/p>\n

MEDIA:<\/b><\/p>\n\n\n\n\n
Logo<\/b><\/font><\/td>\n<\/tr>\n
\"Logo\"<\/td>\n<\/tr>\n
<\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"

Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)– Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company’s request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel has confirmed that Glucotrack has regained compliance with Nasdaq’s stockholders’ equity requirement. The decision represents an important milestone in the Company’s efforts to strengthen its foundation and position for future growth. \u201cThis is an important milestone, but more significantly, it is an acknowledgment of the substantial progress we have made in repositioning Glucotrack for the future,” said Erik Emerson, Chief Executive Officer of Glucotrack. “Over the past several months, we have taken decisive actions … <\/p>\n

Continue reading “Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-995878","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nGlucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)– Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company’s request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel has confirmed that Glucotrack has regained compliance with Nasdaq’s stockholders’ equity requirement. The decision represents an important milestone in the Company’s efforts to strengthen its foundation and position for future growth. \u201cThis is an important milestone, but more significantly, it is an acknowledgment of the substantial progress we have made in repositioning Glucotrack for the future,” said Erik Emerson, Chief Executive Officer of Glucotrack. “Over the past several months, we have taken decisive actions … Continue reading "Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-17T12:03:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation\",\"datePublished\":\"2026-08-17T12:03:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/\"},\"wordCount\":741,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/\",\"name\":\"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en\",\"datePublished\":\"2026-08-17T12:03:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/","og_locale":"en_US","og_type":"article","og_title":"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Market Newsdesk","og_description":"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation RUTHERFORD, N.J. & LA JOLLA, Calif.–(BUSINESS WIRE)– Glucotrack, Inc. (Nasdaq: GCTK) today announced that the Nasdaq Hearings Panel has granted the Company’s request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel has confirmed that Glucotrack has regained compliance with Nasdaq’s stockholders’ equity requirement. The decision represents an important milestone in the Company’s efforts to strengthen its foundation and position for future growth. \u201cThis is an important milestone, but more significantly, it is an acknowledgment of the substantial progress we have made in repositioning Glucotrack for the future,” said Erik Emerson, Chief Executive Officer of Glucotrack. “Over the past several months, we have taken decisive actions … Continue reading \"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/","og_site_name":"Market Newsdesk","article_published_time":"2026-08-17T12:03:53+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation","datePublished":"2026-08-17T12:03:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/"},"wordCount":741,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/","name":"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en","datePublished":"2026-08-17T12:03:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&sty=20260817183116r1&sid=flmnd&distro=nx&lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/glucotrack-achieves-key-compliance-milestone-and-advances-strategic-transformation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Glucotrack Achieves Key Compliance Milestone and Advances Strategic Transformation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/995878","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=995878"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/995878\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=995878"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=995878"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=995878"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}